tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Osteopore Achieves Record Revenue and EU MDR Clearance

Story Highlights
Osteopore Achieves Record Revenue and EU MDR Clearance

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Osteopore Ltd. ( (AU:OSX) ) has issued an update.

Osteopore Limited has reported a record quarterly revenue of AUD 835K for Q2 CY25, marking a 15% increase quarter-on-quarter and an 11% rise year-on-year. The company has also secured EU MDR clearance for its custom orthopaedic and cranial implants, which is expected to open new revenue streams and enhance its market presence in the European Union.

More about Osteopore Ltd.

Osteopore Limited is a manufacturer of regenerative implants that facilitate natural tissue regeneration. The company focuses on producing custom and off-the-shelf orthopaedic and cranial implants, primarily targeting the European market.

Average Trading Volume: 2,491,755

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$2.49M

See more data about OSX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1